Next Generation Sequencing of Prostate Tumors: Use of Individualized Biomarkers for Prognosis and Treatment
Dr. Martin Spahn presented “Next Generation Sequencing of Prostate Tumors: Use of Individualized...
Read MoreSelect Page
Dr. Martin Spahn is a Senior Consultant in the Department of Urology at the Lindenhofspital Bern in Bern, Switzerland. His professional career began in Germany: he graduated in Medicine in 1993 and specialized in Urology and Surgical Urology at the University of Mannheim. In 2007, he was appointed Adjunct Clinical Head at the Department of Urology of the Community Hospital in Karlsruhe, Germany. He then held a position in the Department of Urology and Pediatric Urology at the University Hospital in Würzburg, Germany, where he worked until 2012 before moving to the Inselspital Bern, where he was a Senior Consultant in the Department of Urology until 2018. Dr. Spahn is a member of several scientific societies, including the AUA and the EAU. Dr. Spahn has published over 70 papers in peer-reviewed journals. He is a reviewer for several journals, including European Urology, the British Medical Journal, and the Journal of Urology. He also serves as a grant reviewer for several scientific organisations in Europe, including Cancer Research UK, the German Cancer League, and the Swiss National Fund. He received several awards for his translational research in high-risk prostate cancer, including the Prostate Cancer Research Award of the EAU in 2015 and the Urological Oncology Award of the EAU in 2011.
Disclosures:Posted by Martin Spahn, MD | Feb 2017
Dr. Martin Spahn presented “Next Generation Sequencing of Prostate Tumors: Use of Individualized...
Read More